PROCEPT BioRobotics Corp Quarterly Cost of Revenue in USD from Q3 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
PROCEPT BioRobotics Corp quarterly/annual Cost of Revenue history and growth rate from Q3 2020 to Q2 2024.
  • PROCEPT BioRobotics Corp Cost of Revenue for the quarter ending June 30, 2024 was $21.9M, a 49% increase year-over-year.
  • PROCEPT BioRobotics Corp Cost of Revenue for the twelve months ending June 30, 2024 was $79.9M, a 60.5% increase year-over-year.
  • PROCEPT BioRobotics Corp annual Cost of Revenue for 2023 was $65.1M, a 71.7% increase from 2022.
  • PROCEPT BioRobotics Corp annual Cost of Revenue for 2022 was $37.9M, a 104% increase from 2021.
  • PROCEPT BioRobotics Corp annual Cost of Revenue for 2021 was $18.6M, a 107% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $79.9M $21.9M +$7.2M +49% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-02
Q1 2024 $72.7M $19.5M +$7.59M +63.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $65.1M $22.3M +$9.23M +70.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $55.9M $16.2M +$6.11M +60.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $49.8M $14.7M +$6.47M +78.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-02
Q1 2023 $43.3M $11.9M +$5.41M +83.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $37.9M $13.1M +$7.48M +133% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $30.5M $10.1M +$5.69M +129% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $24.8M $8.21M +$3.31M +67.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-28
Q1 2022 $21.4M $6.51M +$2.84M +77.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $18.6M $5.62M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $4.43M +$2.29M +107% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $4.89M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $3.67M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q3 2020 $2.14M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.